gvtcx

Contract award for Euroimmun Anti-SARS-CoV2 ELISA

Public Health England Published 30 Mar 2021 Contracts Finder
The value below is a framework or dynamic market ceiling: the maximum that could be spent across all call-offs, not the value of a single contract. Aggregate figures on this site exclude these to avoid double counting.

key details

Value£1,500,000
Statuscomplete
Category (CPV) 33141625
RegionSouth West
Deadline12 May 2020
Contract start13 May 2020
Contract end12 Nov 2020
Procedureselective
SME suitableYes
OCIDocds-b5fd17-4e845375-478e-40a6-bad1-c0b785adb94b

Award

SupplierValueDateStatus
Euroimmun UK Limited £1,500,000 11 May 2020 active

description

Public Health England (PHE) has awarded a contract to Euroimmun UK Limited for the supply of Anti-SARS-CoV2 IGA and IGG ELISA for COVID-19 work. This is a 6 month contract with the option to extend by 2 further periods 3 months. This contract has been awarded via. direct award through the PHE Microbiology Framework Lot 1.

notice history

1 notice published against this procurement.

PublishedTypeRegimeNotice
30 Mar 2021 Award update (awardUpdate) · d2e3e80e-79e6-4671-924b-5be78cfb4eb0-424860

more from Public Health England

all contracts from this buyer →

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.